Free Trial

Hamel Associates Inc. Trims Stock Position in Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Hamel Associates Inc. lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 57,207 shares of the company's stock after selling 8,605 shares during the period. Procter & Gamble accounts for 3.3% of Hamel Associates Inc.'s portfolio, making the stock its 8th biggest holding. Hamel Associates Inc.'s holdings in Procter & Gamble were worth $9,749,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Navigoe LLC acquired a new stake in Procter & Gamble in the 4th quarter valued at about $31,000. Capital A Wealth Management LLC acquired a new stake in Procter & Gamble in the 4th quarter valued at about $31,000. Hoey Investments Inc. lifted its holdings in Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company's stock valued at $33,000 after acquiring an additional 148 shares during the last quarter. 10Elms LLP acquired a new stake in Procter & Gamble during the 4th quarter worth about $34,000. Finally, Sunbeam Capital Management LLC acquired a new stake in Procter & Gamble during the 4th quarter worth about $34,000. Institutional investors own 65.77% of the company's stock.

Procter & Gamble Stock Performance

PG traded down $0.53 on Friday, hitting $158.28. The company had a trading volume of 5,799,883 shares, compared to its average volume of 9,070,670. The company's fifty day moving average price is $161.02 and its 200 day moving average price is $164.22. Procter & Gamble Company has a 1-year low of $151.90 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.71 and a quick ratio of 0.50. The stock has a market cap of $371.10 billion, a price-to-earnings ratio of 25.12, a price-to-earnings-growth ratio of 4.52 and a beta of 0.40.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.53 by $0.01. Procter & Gamble had a net margin of 18.46% and a return on equity of 32.67%. The business had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. During the same quarter in the previous year, the firm posted $1.52 earnings per share. Procter & Gamble's revenue was down 2.1% compared to the same quarter last year. Equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be given a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.67%. The ex-dividend date of this dividend is Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is currently 67.14%.

Analyst Ratings Changes

Several research firms have issued reports on PG. Redburn Partners set a $161.00 price objective on Procter & Gamble in a report on Thursday, May 1st. Bank of America cut their price objective on Procter & Gamble from $190.00 to $180.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Raymond James Financial lowered their target price on Procter & Gamble from $190.00 to $185.00 and set an "outperform" rating on the stock in a research note on Friday, April 25th. Erste Group Bank cut Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Finally, Royal Bank Of Canada raised Procter & Gamble from a "sector perform" rating to an "outperform" rating and lifted their target price for the company from $164.00 to $177.00 in a research note on Friday, April 25th. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $176.12.

View Our Latest Report on Procter & Gamble

Insiders Place Their Bets

In related news, CEO Jennifer L. Davis sold 1,000 shares of the company's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total value of $161,380.00. Following the completion of the transaction, the chief executive officer directly owned 51,965 shares in the company, valued at approximately $8,386,111.70. This represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the company's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the transaction, the insider owned 25,182 shares of the company's stock, valued at $3,995,627.94. The trade was a 29.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.18% of the company's stock.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines